{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:11:53Z","timestamp":1770437513363,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2021J291"],"award-info":[{"award-number":["2021J291"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2021J292"],"award-info":[{"award-number":["2021J292"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-026-05100-2","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:33:46Z","timestamp":1770276826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative bioinformatics and machine learning approaches identify novel diagnostic signatures for oxaliplatin-resistant colorectal cancer"],"prefix":"10.1007","volume":"41","author":[{"given":"Xue","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"5100_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"5100_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 14:101174","journal-title":"Transl Oncol"},{"key":"5100_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E (2019) Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol 16:713\u2013732","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5100_CR4","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.cgh.2019.10.009","volume":"18","author":"V Gausman","year":"2020","unstructured":"Gausman V, Dornblaser D, Anand S, Hayes RB, O\u2019Connell K, Du M, Liang PS (2020) Risk factors associated with early-onset colorectal cancer. Clin Gastroenterol Hepatol 18:2752-2759 e2752","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5100_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","volume":"20","author":"AB Benson","year":"2022","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Gunn A, Hecht JR, Hoffe S, Hubbard J, Hunt S, Jeck W, Johung KL, Kirilcuk N, Krishnamurthi S, Maratt JK, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stotsky-Himelfarb E, Tavakkoli A, Willett CG, Gregory K, Gurski L (2022) Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20:1139\u20131167","journal-title":"J Natl Compr Canc Netw"},{"key":"5100_CR6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1586\/14737140.8.8.1223","volume":"8","author":"J Capdevila","year":"2008","unstructured":"Capdevila J, Elez E, Peralta S, Macarulla T, Ramos FJ, Tabernero J (2008) Oxaliplatin-based chemotherapy in the management of colorectal cancer. Expert Rev Anticancer Ther 8:1223\u20131236","journal-title":"Expert Rev Anticancer Ther"},{"key":"5100_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573\u2013584","journal-title":"Nat Rev Cancer"},{"key":"5100_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1472-8206.2007.00462.x","volume":"21","author":"S William-Faltaos","year":"2007","unstructured":"William-Faltaos S, Rouillard D, Lechat P, Bastian G (2007) Cell cycle arrest by oxaliplatin on cancer cells. Fundam Clin Pharmacol 21:165\u2013172","journal-title":"Fundam Clin Pharmacol"},{"key":"5100_CR9","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/sj.bjc.6602215","volume":"91","author":"D Arango","year":"2004","unstructured":"Arango D, Wilson AJ, Shi Q, Corner GA, Aranes MJ, Nicholas C, Lesser M, Mariadason JM, Augenlicht LH (2004) Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br J Cancer 91:1931\u20131946","journal-title":"Br J Cancer"},{"key":"5100_CR10","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1200\/JCO.2014.59.7633","volume":"33","author":"MG Fakih","year":"2015","unstructured":"Fakih MG (2015) Metastatic colorectal cancer: current state and future directions. J Clin Oncol 33:1809\u20131824","journal-title":"J Clin Oncol"},{"key":"5100_CR11","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1158\/1535-7163.MCT-14-0636","volume":"14","author":"E Martinez-Balibrea","year":"2015","unstructured":"Martinez-Balibrea E, Martinez-Cardus A, Gines A, de Ruiz Porras V, Moutinho C, Layos L, Manzano JL, Buges C, Bystrup S, Esteller M, Abad A (2015) Tumor-related molecular mechanisms of oxaliplatin resistance. Mol Cancer Ther 14:1767\u20131776","journal-title":"Mol Cancer Ther"},{"key":"5100_CR12","doi-asserted-by":"crossref","unstructured":"Matthews H, Hanison J, Nirmalan N (2016) \"Omics\"-informed drug and biomarker discovery: opportunities, challenges and future perspectives. Proteomes 4(3):28","DOI":"10.3390\/proteomes4030028"},{"key":"5100_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108201","volume":"171","author":"H Tang","year":"2024","unstructured":"Tang H, Luo X, Shen X, Fan D, Rao J, Wan Y, Ma H, Guo X, Liu Z, Gao J (2024) Lysosome-related biomarkers in preeclampsia and cancers: machine learning and bioinformatics analysis. Comput Biol Med 171:108201","journal-title":"Comput Biol Med"},{"key":"5100_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2023.102589","volume":"143","author":"T Yuan","year":"2023","unstructured":"Yuan T, Edelmann D, Fan Z, Alwers E, Kather JN, Brenner H, Hoffmeister M (2023) Machine learning in the identification of prognostic DNA methylation biomarkers among patients with cancer: a systematic review of epigenome-wide studies. Artif Intell Med 143:102589","journal-title":"Artif Intell Med"},{"key":"5100_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097781","author":"Q Al-Tashi","year":"2023","unstructured":"Al-Tashi Q, Saad MB, Muneer A, Qureshi R, Mirjalili S, Sheshadri A, Le X, Vokes NI, Zhang J, Wu J (2023) Machine learning models for the identification of prognostic and predictive cancer biomarkers: a systematic review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24097781","journal-title":"Int J Mol Sci"},{"key":"5100_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12184","volume":"20","author":"AM Gravett","year":"2020","unstructured":"Gravett AM, Dennis JL, Dalgleish AG, Copier J, Liu WM (2020) The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agents. Oncol Lett 20:321","journal-title":"Oncol Lett"},{"key":"5100_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144708","volume":"10","author":"R Briffa","year":"2015","unstructured":"Briffa R, Um I, Faratian D, Zhou Y, Turnbull AK, Langdon SP, Harrison DJ (2015) Multi-scale genomic, transcriptomic and proteomic analysis of colorectal cancer cell lines to identify novel biomarkers. PLoS ONE 10:e0144708","journal-title":"PLoS ONE"},{"key":"5100_CR18","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.molonc.2015.02.008","volume":"9","author":"NF Jensen","year":"2015","unstructured":"Jensen NF, Stenvang J, Beck MK, Hanakova B, Belling KC, Do KN, Viuff B, Nygard SB, Gupta R, Rasmussen MH, Tarpgaard LS, Hansen TP, Budinska E, Pfeiffer P, Bosman F, Tejpar S, Roth A, Delorenzi M, Andersen CL, Romer MU, Brunner N, Moreira JM (2015) Establishment and characterization of models of chemotherapy resistance in colorectal cancer: towards a predictive signature of chemoresistance. Mol Oncol 9:1169\u20131185","journal-title":"Mol Oncol"},{"key":"5100_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0558-5","volume":"36","author":"S Cherradi","year":"2017","unstructured":"Cherradi S, Ayrolles-Torro A, Vezzo-Vie N, Gueguinou N, Denis V, Combes E, Boissiere F, Busson M, Canterel-Thouennon L, Mollevi C, Pugniere M, Bibeau F, Ychou M, Martineau P, Gongora C, Del Rio M (2017) Antibody targeting of claudin-1 as a potential colorectal cancer therapy. J Exp Clin Cancer Res 36:89","journal-title":"J Exp Clin Cancer Res"},{"key":"5100_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD (2012) The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28:882\u2013883","journal-title":"Bioinformatics"},{"key":"5100_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284\u2013287","journal-title":"OMICS"},{"key":"5100_CR22","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214-220","journal-title":"Nucleic Acids Res"},{"key":"5100_CR23","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, Jeon M, Kang J, Tan AC (2015) DSigDB: drug signatures database for gene set analysis. Bioinformatics 31:3069\u20133071","journal-title":"Bioinformatics"},{"key":"5100_CR24","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang X, Gan J, Chen S, Xiao ZX, Cao Y (2022) CB-dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res 50:W159\u2013W164","journal-title":"Nucleic Acids Res"},{"key":"5100_CR25","doi-asserted-by":"publisher","first-page":"18180","DOI":"10.1002\/jcp.28451","volume":"234","author":"X Wang","year":"2019","unstructured":"Wang X, Ghareeb WM, Zhang Y, Yu Q, Lu X, Huang Y, Huang S, Sun Y, Chi P (2019) Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer. J Cell Physiol 234:18180\u201318191","journal-title":"J Cell Physiol"},{"key":"5100_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1593\/tlo.08109","volume":"1","author":"LM Privette","year":"2008","unstructured":"Privette LM, Petty EM (2008) CHFR: a novel mitotic checkpoint protein and regulator of tumorigenesis. Transl Oncol 1:57\u201364","journal-title":"Transl Oncol"},{"key":"5100_CR27","first-page":"151","volume":"19","author":"M Guo","year":"2015","unstructured":"Guo M, Alumkal J, Drachova T, Gao D, Marina SS, Jen J, Herman JG (2015) CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer. Discov Med 19:151\u2013158","journal-title":"Discov Med"},{"key":"5100_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbrc.2021.08.011","volume":"573","author":"W Wu","year":"2021","unstructured":"Wu W, Zhao J, Xiao J, Wu W, Xie L, Xie X, Yang C, Yin D, Hu K (2021) CHFR-mediated degradation of RNF126 confers sensitivity to PARP inhibitors in triple-negative breast cancer cells. Biochem Biophys Res Commun 573:62\u201368","journal-title":"Biochem Biophys Res Commun"},{"key":"5100_CR29","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.1073\/pnas.1337066100","volume":"100","author":"M Toyota","year":"2003","unstructured":"Toyota M, Sasaki Y, Satoh A, Ogi K, Kikuchi T, Suzuki H, Mita H, Tanaka N, Itoh F, Issa JP, Jair KW, Schuebel KE, Imai K, Tokino T (2003) Epigenetic inactivation of CHFR in human tumors. Proc Natl Acad Sci U S A 100:7818\u20137823","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5100_CR30","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1016\/j.ejca.2013.06.001","volume":"49","author":"Y Han","year":"2013","unstructured":"Han Y, Cai H, Ma L, Ding Y, Tan X, Liu Y, Su T, Yu Y, Chang W, Zhang H, Fu C, Cao G (2013) Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy. Eur J Cancer 49:3420\u20133430","journal-title":"Eur J Cancer"},{"key":"5100_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2174\/187152012803529619","volume":"12","author":"AJ Deutsch","year":"2012","unstructured":"Deutsch AJ, Angerer H, Fuchs TE, Neumeister P (2012) The nuclear orphan receptors NR4A as therapeutic target in cancer therapy. Anticancer Agents Med Chem 12:1001\u20131014","journal-title":"Anticancer Agents Med Chem"},{"key":"5100_CR32","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1158\/1541-7786.MCR-17-0002","volume":"15","author":"K Yin","year":"2017","unstructured":"Yin K, Chhabra Y, Tropee R, Lim YC, Fane M, Dray E, Sturm RA, Smith AG (2017) NR4A2 promotes DNA double-strand break repair upon exposure to UVR. Mol Cancer Res 15:1184\u20131196","journal-title":"Mol Cancer Res"},{"key":"5100_CR33","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.bcp.2012.01.030","volume":"83","author":"Y Chen","year":"2012","unstructured":"Chen Y, Tang Y, Guo C, Wang J, Boral D, Nie D (2012) Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochem Pharmacol 83:1112\u20131126","journal-title":"Biochem Pharmacol"},{"key":"5100_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402327","volume":"11","author":"K Liu","year":"2024","unstructured":"Liu K, Tian F, Chen X, Liu B, Tian S, Hou Y, Wang L, Han M, Peng S, Tan Y, Pan Y, Chu Z, Li J, Che L, Chen D, Wen L, Qin Z, Li X, Xiang J, Bian XW, Liu Q, Ye X, Wang T, Wang B (2024) Stabilization of TGF-beta receptor 1 by a receptor-associated adaptor dictates feedback activation of the TGF-beta signaling pathway to maintain liver cancer stemness and drug resistance. Adv Sci (Weinh) 11:e2402327","journal-title":"Adv Sci (Weinh)"},{"key":"5100_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bbrc.2015.12.021","volume":"469","author":"X He","year":"2016","unstructured":"He X, Liu Z, Peng Y, Yu C (2016) Microrna-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-beta pathway. Biochem Biophys Res Commun 469:1041\u20131048","journal-title":"Biochem Biophys Res Commun"},{"key":"5100_CR36","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00262-023-03474-8","volume":"72","author":"C Battin","year":"2023","unstructured":"Battin C, De Sousa Linhares A, Leitner J, Grossmann A, Lupinek D, Izadi S, Castilho A, Waidhofer-Sollner P, Grabmeier-Pfistershammer K, Stritzker J, Steinberger P (2023) Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents. Cancer Immunol Immunother 72:3029\u20133043","journal-title":"Cancer Immunol Immunother"},{"key":"5100_CR37","first-page":"431","volume":"38","author":"X Shen","year":"2023","unstructured":"Shen X, Zhang R, Nie X, Yang Y, Hua Y, Lu P (2023) 4\u20131BB targeting immunotherapy: mechanism, antibodies, and chimeric antigen receptor T. Cancer Biother Radiopharm 38:431\u2013444","journal-title":"Cancer Biother Radiopharm"},{"key":"5100_CR38","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1083\/jcb.152.5.1079","volume":"152","author":"T Fujimoto","year":"2001","unstructured":"Fujimoto T, Kogo H, Ishiguro K, Tauchi K, Nomura R (2001) Caveolin-2 is targeted to lipid droplets, a new \u201cmembrane domain\u201d in the cell. J Cell Biol 152:1079\u20131085","journal-title":"J Cell Biol"},{"key":"5100_CR39","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1046\/j.1471-4159.2003.02081.x","volume":"87","author":"J Jodoin","year":"2003","unstructured":"Jodoin J, Demeule M, Fenart L, Cecchelli R, Farmer S, Linton KJ, Higgins CF, Beliveau R (2003) P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins. J Neurochem 87:1010\u20131023","journal-title":"J Neurochem"},{"key":"5100_CR40","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1073\/pnas.120161397","volume":"97","author":"JA White","year":"2000","unstructured":"White JA, Ramshaw H, Taimi M, Stangle W, Zhang A, Everingham S, Creighton S, Tam SP, Jones G, Petkovich M (2000) Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc Natl Acad Sci U S A 97:6403\u20136408","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5100_CR41","first-page":"1827","volume":"125","author":"J Okano","year":"2012","unstructured":"Okano J, Lichti U, Mamiya S, Aronova M, Zhang G, Yuspa SH, Hamada H, Sakai Y, Morasso MI (2012) Increased retinoic acid levels through ablation of Cyp26b1 determine the processes of embryonic skin barrier formation and peridermal development. J Cell Sci 125:1827\u20131836","journal-title":"J Cell Sci"},{"key":"5100_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/jmcb\/mjv014","volume":"7","author":"X Zhou","year":"2015","unstructured":"Zhou X, Liao WJ, Liao JM, Liao P, Lu H (2015) Ribosomal proteins: functions beyond the ribosome. J Mol Cell Biol 7:92\u2013104","journal-title":"J Mol Cell Biol"},{"key":"5100_CR43","doi-asserted-by":"publisher","first-page":"17394","DOI":"10.1073\/pnas.1120799109","volume":"109","author":"MV Gerashchenko","year":"2012","unstructured":"Gerashchenko MV, Lobanov AV, Gladyshev VN (2012) Genome-wide ribosome profiling reveals complex translational regulation in response to oxidative stress. Proc Natl Acad Sci U S A 109:17394\u201317399","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5100_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01134-6","volume":"15","author":"X Yin","year":"2024","unstructured":"Yin X, Zhang H, Wang J, Bian Y, Jia Q, Yang Z, Shan C (2024) LncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin. Discover Oncol 15:265","journal-title":"Discover Oncol"},{"key":"5100_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24754","volume":"36","author":"D Yi","year":"2022","unstructured":"Yi D, Xu F, Wang R, Jiang C, Qin J, Lee Y, Shi X, Sang J (2022) Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer. J Clin Lab Anal 36:e24754","journal-title":"J Clin Lab Anal"},{"key":"5100_CR46","doi-asserted-by":"crossref","unstructured":"Sever T, Ellidokuz EB, Basbinar Y, Ellidokuz H, Yilmaz OH, Calibasi-Kocal G (2023) Beta-Hydroxybutyrate Augments oxaliplatin-induced cytotoxicity by altering energy metabolism in colorectal cancer organoids. Cancers (Basel) 15(24):5724","DOI":"10.3390\/cancers15245724"},{"key":"5100_CR47","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.7150\/thno.84937","volume":"13","author":"J Deng","year":"2023","unstructured":"Deng J, Pan T, Lv C, Cao L, Li L, Zhou X, Li G, Li H, Vicencio JM, Xu Y, Wei F, Wang Y, Liu Z, Zhou G, Yin M (2023) Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer. Theranostics 13:5057\u20135074","journal-title":"Theranostics"},{"key":"5100_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112369","volume":"398","author":"L Shen","year":"2021","unstructured":"Shen L, Zhou L, Xia M, Lin N, Ma J, Dong D, Sun L (2021) PGC1alpha regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback. Exp Cell Res 398:112369","journal-title":"Exp Cell Res"},{"key":"5100_CR49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378","journal-title":"Eur J Pharmacol"},{"key":"5100_CR50","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1002\/1878-0261.13227","volume":"16","author":"T Helleday","year":"2022","unstructured":"Helleday T, Rudd SG (2022) Targeting the DNA damage response and repair in cancer through nucleotide metabolism. Mol Oncol 16:3792\u20133810","journal-title":"Mol Oncol"},{"key":"5100_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.616469","volume":"12","author":"Y Lv","year":"2021","unstructured":"Lv Y, Lv D, Lv X, Xing P, Zhang J, Zhang Y (2021) Immune cell infiltration-based characterization of triple-negative breast cancer predicts prognosis and chemotherapy response markers. Front Genet 12:616469","journal-title":"Front Genet"},{"key":"5100_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08328-z","volume":"21","author":"L He","year":"2021","unstructured":"He L, Yang H, Huang J (2021) The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma. BMC Cancer 21:581","journal-title":"BMC Cancer"},{"key":"5100_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yexcr.2017.12.005","volume":"363","author":"Q Li","year":"2018","unstructured":"Li Q, Huang Q, Huyan T, Wang Y, Huang Q, Shi J (2018) Bifacial effects of engineering tumour cell-derived exosomes on human natural killer cells. Exp Cell Res 363:141\u2013150","journal-title":"Exp Cell Res"},{"key":"5100_CR54","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41590-022-01324-w","volume":"23","author":"R Wu","year":"2022","unstructured":"Wu R, Ohara RA, Jo S, Liu TT, Ferris ST, Ou F, Kim S, Theisen DJ, Anderson DA 3rd, Wong BW, Gershon T, Schreiber RD, Murphy TL, Murphy KM (2022) Mechanisms of CD40-dependent cDC1 licensing beyond costimulation. Nat Immunol 23:1536\u20131550","journal-title":"Nat Immunol"},{"key":"5100_CR55","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12935-023-03149-5","volume":"23","author":"D Song","year":"2023","unstructured":"Song D, Zhao L, Zhao G, Hao Q, Wu J, Ren H, Zhang B (2023) Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma. Cancer Cell Int 23:322","journal-title":"Cancer Cell Int"},{"key":"5100_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.101377","volume":"18","author":"W Liu","year":"2024","unstructured":"Liu W, Zhang F, Quan B, Yao F, Chen R, Ren Z, Dong L, Yin X (2024) DDR2\/STAT3 positive feedback loop mediates the immunosuppressive microenvironment by upregulating PD-L1 and recruiting MDSCs in oxaliplatin-resistant HCC. Cell Mol Gastroenterol Hepatol 18:101377","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"5100_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2024.07.015","volume":"373","author":"Z Gu","year":"2024","unstructured":"Gu Z, Yin J, Da Silva CG, Liu Q, Cruz LJ, Ossendorp F, Snaar-Jagalska E (2024) Therapeutic liposomal combination to enhance chemotherapy response and immune activation of tumor microenvironment. J Control Release 373:38\u201354","journal-title":"J Control Release"},{"key":"5100_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104457","volume":"202","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Na C, Li Z (2024) Novel insights into immune cells modulation of tumor resistance. Crit Rev Oncol Hematol 202:104457","journal-title":"Crit Rev Oncol Hematol"},{"key":"5100_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091075","author":"S Makaremi","year":"2021","unstructured":"Makaremi S, Asadzadeh Z, Hemmat N, Baghbanzadeh A, Sgambato A, Ghorbaninezhad F, Safarpour H, Argentiero A, Brunetti O, Bernardini R, Silvestris N, Baradaran B (2021) Immune checkpoint inhibitors in colorectal cancer: challenges and future prospects. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9091075","journal-title":"Biomedicines"},{"key":"5100_CR60","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.7150\/ijbs.64077","volume":"17","author":"A Fan","year":"2021","unstructured":"Fan A, Wang B, Wang X, Nie Y, Fan D, Zhao X, Lu Y (2021) Immunotherapy in colorectal cancer: current achievements and future perspective. Int J Biol Sci 17:3837\u20133849","journal-title":"Int J Biol Sci"},{"key":"5100_CR61","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","volume":"556","author":"SF Roerink","year":"2018","unstructured":"Roerink SF, Sasaki N, Lee-Six H, Young MD, Alexandrov LB, Behjati S, Mitchell TJ, Grossmann S, Lightfoot H, Egan DA (2018) Intra-tumour diversification in colorectal cancer at the single-cell level. Nature 556:457\u2013462","journal-title":"Nature"},{"key":"5100_CR62","doi-asserted-by":"crossref","unstructured":"Fumagalli A, Oost KC, Kester L,\u00a0 Morgner J, Bornes L, Bruens L, Spaargaren L, Azkanaz M, Schelfhorst T, Beerling E (2020) Plasticity of Lgr5-negative cancer cells drives metastasis in colorectal cancer, Cell stem cell, 2 569-578. e567","DOI":"10.1016\/j.stem.2020.02.008"},{"key":"5100_CR63","doi-asserted-by":"crossref","unstructured":"Zhang L, Yu X, Zheng  L, Zhang Y, Li Y, Fang Q, Gao R, Kang B, Zhang Q, Huang  JY\u00a0(2018) Lineage tracking reveals dynamic relationships of T cells in colorectal cancer, Nature, 564\u00a0 268-272","DOI":"10.1038\/s41586-018-0694-x"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-026-05100-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-026-05100-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-026-05100-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:03:50Z","timestamp":1770347030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-026-05100-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5100"],"URL":"https:\/\/doi.org\/10.1007\/s00384-026-05100-2","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed the ethical standards of the 1964 Declaration of Helsinki and its later amendments. Ethical approval was not required for the study involving humans in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent to participate in this study was not required from the participants or the participants\u2019 legal guardians\/next of kin in accordance with the national legislation and the institutional requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}